Free Trial

Hoth Therapeutics (HOTH) Competitors

Hoth Therapeutics logo
$1.28 -0.02 (-1.54%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.29 +0.01 (+0.86%)
As of 07/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HOTH vs. APLT, RPTX, CRVO, ASRT, STRO, HOWL, SCLX, IKNA, BRNS, and MNOV

Should you be buying Hoth Therapeutics stock or one of its competitors? The main competitors of Hoth Therapeutics include Applied Therapeutics (APLT), Repare Therapeutics (RPTX), CervoMed (CRVO), Assertio (ASRT), Sutro Biopharma (STRO), Werewolf Therapeutics (HOWL), Scilex (SCLX), Ikena Oncology (IKNA), Barinthus Biotherapeutics (BRNS), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry.

Hoth Therapeutics vs. Its Competitors

Hoth Therapeutics (NASDAQ:HOTH) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Hoth Therapeutics' return on equity of -109.18% beat Applied Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Hoth TherapeuticsN/A -109.18% -100.22%
Applied Therapeutics N/A -184.67%-84.02%

In the previous week, Hoth Therapeutics had 1 more articles in the media than Applied Therapeutics. MarketBeat recorded 4 mentions for Hoth Therapeutics and 3 mentions for Applied Therapeutics. Applied Therapeutics' average media sentiment score of 0.88 beat Hoth Therapeutics' score of 0.47 indicating that Applied Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hoth Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Applied Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hoth Therapeutics has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500.

Hoth Therapeutics presently has a consensus price target of $4.00, suggesting a potential upside of 212.50%. Applied Therapeutics has a consensus price target of $6.10, suggesting a potential upside of 1,170.83%. Given Applied Therapeutics' higher possible upside, analysts plainly believe Applied Therapeutics is more favorable than Hoth Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hoth Therapeutics
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Applied Therapeutics
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

7.1% of Hoth Therapeutics shares are owned by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are owned by institutional investors. 6.9% of Hoth Therapeutics shares are owned by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hoth Therapeutics has higher earnings, but lower revenue than Applied Therapeutics. Hoth Therapeutics is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hoth TherapeuticsN/AN/A-$8.19M-$1.14-1.12
Applied Therapeutics$460K147.74-$105.62M-$0.43-1.12

Summary

Applied Therapeutics beats Hoth Therapeutics on 8 of the 14 factors compared between the two stocks.

Get Hoth Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HOTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HOTH vs. The Competition

MetricHoth TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$17.17M$3.06B$5.69B$9.50B
Dividend YieldN/A2.37%4.58%4.01%
P/E Ratio-1.1221.1828.1020.05
Price / SalesN/A288.62432.4890.19
Price / CashN/A42.7636.2258.56
Price / Book1.498.378.665.87
Net Income-$8.19M-$55.19M$3.25B$258.55M
7 Day Performance2.40%5.88%4.22%3.73%
1 Month Performance9.40%17.33%10.51%11.75%
1 Year Performance53.35%4.42%34.40%18.03%

Hoth Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOTH
Hoth Therapeutics
2.9209 of 5 stars
$1.28
-1.5%
$4.00
+212.5%
+58.0%$17.17MN/A-1.124Positive News
Analyst Forecast
APLT
Applied Therapeutics
4.4061 of 5 stars
$0.46
-0.4%
$6.10
+1,226.1%
-90.8%$65.39M$460K-1.0730News Coverage
Analyst Upgrade
RPTX
Repare Therapeutics
2.6591 of 5 stars
$1.50
-0.7%
$4.50
+200.0%
-60.0%$64.77M$53.48M-0.50180
CRVO
CervoMed
3.5565 of 5 stars
$8.43
+13.8%
$22.57
+167.8%
-37.5%$64.49M$9.74M-3.874News Coverage
Analyst Forecast
ASRT
Assertio
2.3167 of 5 stars
$0.70
+3.3%
$2.75
+295.7%
-49.7%$64.46M$124.96M-2.1720Positive News
STRO
Sutro Biopharma
4.162 of 5 stars
$0.80
+5.3%
$6.11
+664.3%
-79.3%$64.19M$62.04M-0.27240News Coverage
HOWL
Werewolf Therapeutics
4.0485 of 5 stars
$1.40
-0.7%
$8.33
+495.2%
-50.4%$63.27M$1.88M-0.8440
SCLX
Scilex
2.3844 of 5 stars
$8.60
-2.9%
$455.00
+5,190.7%
-79.9%$61.59M$56.59M-0.3080News Coverage
IKNA
Ikena Oncology
2.827 of 5 stars
$1.27
flat
$3.00
+136.2%
-14.9%$61.29M$9.16M-1.4870News Coverage
Earnings Report
Analyst Forecast
Stock Split
High Trading Volume
BRNS
Barinthus Biotherapeutics
3.608 of 5 stars
$1.97
+31.5%
$6.25
+217.3%
+22.6%$60.41M$14.97M-1.20107Positive News
Gap Up
High Trading Volume
MNOV
MediciNova
1.607 of 5 stars
$1.26
+2.4%
$7.00
+455.6%
+12.3%$60.33M$1M-5.4810News Coverage
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:HOTH) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners